Home / Inspections / 1293102

1293102

Apertus Pharmaceuticals — FEI 3010401502

Inspection Details

Classification: Voluntary Action Indicated (VAI) (VAI)
End Date: October 31, 2025
Fiscal Year: 2026
Product Type: Drugs
Project Area: Drug Quality Assurance
Location: Ballwin, MO (United States)